AMOXICILLIN VERSUS AMOXICILLIN-CLAVULANATE VERSUS PLACEBO IN ACUTE OTITIS MEDIA IN CHILDREN – A PARALLEL-GROUP TRIPLE-BLINDED RANDOMIZED CONTROLLED SUPERIORITY TRIAL
This research study is looking at treatments for a common type of ear infection in children, called acute otitis media. Researchers are comparing two different antibiotic medicines, called amoxicillin and amoxicillin-clavulanate, with a dummy treatment (placebo). They want to find out which treatment helps children get better fastest and most completely. The study will pay close attention to how children are feeling each day and check for improvements in their ear infection symptoms. They will also look at how many children might need extra medicine or if they experience any side effects. The aim is to help doctors understand the best way to treat these ear infections.
At a glance
What is this study about?
This study is all about finding the best way to treat common ear infections in children, known scientifically as acute otitis media. When children get these infections, they can be very uncomfortable, causing pain and fever. Doctors often prescribe antibiotics, but it's important to understand which ones work best and when they are truly needed.
In this research, doctors are comparing two widely used antibiotics, amoxicillin and a combination called amoxicillin-clavulanate, with a placebo. A placebo is a dummy treatment that looks just like the real medicine but contains no active ingredients. This helps researchers understand if the antibiotics are genuinely making a difference or if children get better on their own. By comparing these treatments, the study aims to give clearer guidance to doctors on the most effective approach for different situations.
The main goal is to see how quickly and completely children recover from their ear infection symptoms with each treatment. They'll also be looking at other important things, like whether children need another course of antibiotics, if the ear infection comes back, or if there are any side effects like tummy upsets or rashes. This information is vital for improving how we treat children's ear infections in the best and safest way possible.
Key takeaways
- This study compares two antibiotics and a dummy treatment for children's ear infections.
- The goal is to find the most effective and safest treatment for acute otitis media.
- Children will have regular check-ups to monitor their progress.
- Participation lasts about two weeks with daily checks initially.
- You won't know which treatment your child receives during the study.
- You can withdraw your child from the study at any time.
Who may be eligible?
This study is looking for children to take part, but we don't have detailed information here about specific age limits or other health conditions they might need to meet. Generally, children with acute otitis media (a type of ear infection) are likely to be considered.
Since this information is very brief, if you are interested in your child taking part, it's very important to speak with a doctor or the research team. They will be able to tell you exactly who can and cannot join the study based on more detailed health requirements.
- Is my child currently suffering from an acute ear infection (acute otitis media)?
- Is my child within the age range specified by the study (you'll need to ask the doctor)?
- Does my child have any other serious health conditions that might prevent them from joining?
- Am I comfortable with my child potentially receiving a placebo?
- Am I able to bring my child to regular study appointments?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If a child takes part in this study, they will receive one of three treatments: amoxicillin, amoxicillin-clavulanate, or a dummy treatment (placebo). No one, not the patient, the family, or the study doctors, will know which treatment the child is getting until the study is over. This helps ensure fair results.
The study involves regular check-ups to see how the child is feeling and how their ear infection is progressing. These check-ups will happen daily for the first week, then again around day 10 and day 14. During these visits, doctors will assess the child's overall condition and may look inside their ears. If a child's condition worsens, or they don't improve, the study doctors may decide they need different medicine. The total length of active participation, including follow-up, will be around two weeks.
Potential risks and benefits
Locations (1)
- —Finland
Common questions
What is acute otitis media?
Acute otitis media is a common type of ear infection, often caused by bacteria or viruses, that mainly affects the middle part of the ear and can cause pain and fever.
What is a 'placebo'?
A placebo is a dummy treatment that looks exactly like the real medicine but doesn't contain any active drug. It helps researchers see if the actual medicine is truly working or if people get better on their own.
Why are doctors using different treatments?
Doctors are comparing different treatments (two antibiotics and a placebo) to find out which one works best and is safest for treating ear infections in children.
Will my child definitely get antibiotics?
No, your child might receive one of the two antibiotics or the placebo (dummy treatment) as part of the study. You won't know which one they are getting until the study ends.
What happens if my child doesn't get better?
If your child's condition doesn't improve or gets worse during the study, the study doctors will take appropriate steps, which may include providing different medication.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.